A&D Original Ointment, Diaper Rash Ointment & Skin Protectant, 16 oz. Jar, Bayer Healthcare Pharmaceutica, NDC 11523-0096-3.
Published August 17, 2022 · Recall initiated: June 29, 2022
Summary
FDA records drug Class II recall D-1322-2022, published August 17, 2022 and initiated June 29, 2022. Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office; Status: Terminated; Reported quantity: 1 Jar. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: products were stored outside the drug label specifications.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Distributor
- Nationwide in the USA.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.July 30, 2025
- FDAPROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc.,July 30, 2025
- FDAEVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by:July 30, 2025
- FDASEKISUI DIAGNOSTICS LLC SERUM HCG OSOMGENZME CONTROL SET.June 4, 2025
- FDAPataday, Once Daily Relief, Olopatadine hydrochloride ophthalmic solution 0.2%, Antihistamine, Eye AllergyAugust 17, 2022
- FDADakin's Solution, a) sodium hypochlorite 0.125%, quarter strength, NDC 0436-0672-16, b) sodium hypochloriteAugust 17, 2022
Questions about this recall
Was A&D Original Ointment, Diaper Rash Ointment & Skin Protectant, 16 oz. Jar, Bayer Healthcare Pharmaceutica, NDC 11523-0096-3. recalled?
Yes. FDA published recall D-1322-2022 on August 17, 2022. Reported hazard: CGMP Deviations: products were stored outside the drug label specifications.
What should I do if I have this product?
Voluntary: Firm initiated · Letter